Salomon Azoulay
Chief Medical Officer at MBX Biosciences, Inc. (MBX)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $2.7M
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Aug 5SEC | MBXMBX Biosciences, Inc. | Sell | 37014,399 held (−3%) | $65.77 | $24K | -24.6% |
| May 11SEC | MBXMBX Biosciences, Inc. | Sell Plan | 55,00014,769 held (−79%) | $38.38 | $2.1M | +29.3% |
| May 11SEC | MBXMBX Biosciences, Inc. | Sell Plan | 15,00314,769 held (−50%) | $38.30 | $575K | +29.5% |
| May 8SEC | MBXMBX Biosciences, Inc. | Sell | 23114,769 held (−2%) | $29.54 | $7K | +67.9% |
- Sell
Chief Medical Officer Salomon Azoulay sold $2.1M of MBX at $38.38 — cuts the stake by 79%; pre-scheduled 10b5-1 plan sale.
- Sell
Chief Medical Officer Salomon Azoulay sold $575K of MBX at $38.30 — cuts the stake by 50%; pre-scheduled 10b5-1 plan sale.